Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Genetic Technologies Ltd (NASDAQ:GENE)

During the Trading Day
2.96 -0.23 / -7.21%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
3.00 +0.04 / +1.35%
Volume: 8.9K
Health Technology

Company Description

Genetic Technologies Ltd. engages in the business of genetic testing services. The company performs a variety of genetic tests on humans and animals which includes human diagnostics, forensics and animal pedigree tests. It operates through the following segments: Operations, Licensing and Research. The Operations segment involves the provision of a range of genetic testing services. The Licensing segment involves the out-licensing of its intellectual property relating to """"""""non-coding DNA"""""""" technology. The Research segment involves the undertaking of a range of research and development projects in the field of genetics and related areas. Genetic Technologies was founded on January 5, 1987 and is headquartered in Fitzroy, Australia.

Contact Information

Genetic Technologies Ltd.
60-66 Hanover Street
Fitzroy Victoria (vic) 3065
P:(138) 412-7000
Investor Relations:



Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Eutillio BuccilliDirector, Chief Executive & Operating Officer
Brian H. ManuelChief Financial Officer
Richard AllmanScientific Director
Diana NewportDirector-Quality & Business Operations
Bronwyn ChristieSecretary & Financial Controller